@article{oai:nagoya.repo.nii.ac.jp:02000205,
 author = {Kanematsu, Takeshi and Suzuki, Nobuaki and Tamura, Shogo and Suzuki, Atsuo and Ishikawa, Yuichi and Katsumi, Akira and Kiyoi, Hitoshi and Saito, Hidehiko and Kunishima, Shinji and Kojima, Tetsuhito and Matsushita, Tadashi},
 issue = {1},
 journal = {Nagoya Journal of Medical Science},
 month = {Feb},
 note = {Myh9 disorders are characterized by giant platelets, thrombocytopenia, and Döhle body-like cytoplasmic inclusion bodies in granulocytes. However, whether these disorders cause any changes in erythroid cells has yet to be determined. This study analyzed the influence of Myh9 R702C, as one of the most commonly detected Myh9 disorders, on erythroid cells in a mouse model.
Knock-in mice expressing Myh9 R702C mutation either systemically or specific to hematological cells (R702C and R702C vav1 mice, respectively) were used in this study. Both displayed lower hemoglobin and higher erythropoietin levels than wild-type (WT) mice, along with significant splenomegaly. Flow cytometric analysis revealed erythroblasts present at a higher rate than WT mice in the spleen. However, no obvious abnormalities were seen in erythroid differentiation from megakaryocyte/erythroid progenitor to erythrocyte. Cell culture assay by fetal liver and colony assay also showed normal progression of erythroid differentiation from erythroid burst-forming unit to red blood cell.
In conclusion, R702C and R702C vav1 mice displayed erythroid abnormality with splenomegaly. However, erythroid differentiation showed no obvious abnormality. Further research is required to elucidate the underlying mechanisms.},
 pages = {75--86},
 title = {Myh9 R702C is associated with erythroid abnormality with splenomegaly in mice},
 volume = {83},
 year = {2021}
}